---
title: "MOSES ALAN CHARLES — Ownership Dossier"
canonical: https://whiteintel.dev/entity/987dedca-8a87-57e9-a5fc-d02c9f635f21
json: https://whiteintel.dev/api/public/dossier/987dedca-8a87-57e9-a5fc-d02c9f635f21
identifier: sec:0001819501
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MOSES ALAN CHARLES

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001819501`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/987dedca-8a87-57e9-a5fc-d02c9f635f21  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/987dedca-8a87-57e9-a5fc-d02c9f635f21  

## Ownership & control

### Holdings / subsidiaries

- **ANCHIANO THERAPEUTICS LTD.** (director) — https://whiteintel.dev/entity/0381ce02-8845-510d-90dc-f06c29c9cd7a
- **BiomX Inc.** (director) — https://whiteintel.dev/entity/01db328a-2c28-529d-960d-509fc7406f11

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MOSES ALAN CHARLES**. Human view: https://whiteintel.dev/entity/987dedca-8a87-57e9-a5fc-d02c9f635f21 · Structured JSON: https://whiteintel.dev/api/public/dossier/987dedca-8a87-57e9-a5fc-d02c9f635f21._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._